MEG3 was the first tumour suppressor lncRNA identified, has been demonstrated to have a pathogenic role in a number of cancer models [54, 55], and is down-regulated in a number of primary tumours in comparison to matched normal tissues [56, 57]. This evidence concerns the gene MEG3 and neoplasm.